| Schedule of Basic and Diluted Net Loss |
The calculation of basic and diluted net loss per share attributable to common stock was as follows (amounts in thousands except share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Numerator: |
|
|
|
|
|
|
|
| Net loss attributable to common stock—basic and diluted |
$ |
(4,357) |
|
|
$ |
(8,121) |
|
|
$ |
(13,594) |
|
|
$ |
(15,342) |
|
| Denominator: |
|
|
|
|
|
|
|
| Weighted-average basic and diluted shares outstanding |
29,569,936 |
|
|
20,429,791 |
|
|
26,844,457 |
|
19,792,773 |
|
|
|
|
|
|
|
|
| Net loss per share attributable to common stock—basic and diluted |
$ |
(0.15) |
|
|
$ |
(0.40) |
|
|
$ |
(0.51) |
|
|
$ |
(0.78) |
|
|
| Schedule of Outstanding Shares of Common Stock Equivalents |
The following outstanding shares of common stock equivalents were excluded from the computation of the diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Stock options |
147,707 |
|
|
147,707 |
|
|
147,707 |
|
147,707 |
| Non-vested restricted stock awards |
138,408 |
|
|
826,315 |
|
|
138,408 |
|
826,315 |
| Non-vested restricted stock units |
2,270,600 |
|
|
2,777,715 |
|
|
2,270,600 |
|
2,777,715 |
| Common stock warrants |
240,100 |
|
|
240,100 |
|
|
240,100 |
|
240,100 |
| Convertible debt |
1,176,471 |
|
|
1,759,804 |
|
|
1,176,471 |
|
1,759,804 |
|